ABIOMED INC Quarterly Return On Equity in % from Q4 2011 to Q3 2022

Taxonomy & unit: ratio: %
Description: Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary: Abiomed Inc quarterly/annual Return On Equity history and growth rate from Q4 2011 to Q3 2022.
Abiomed Inc Return On Equity for the quarter ending September 30, 2022 was 17.8 %, a 57.2% increase year-over-year.
Abiomed Inc annual Return On Equity for 2021 was 11.2 %, a 49% decline from 2020.
Abiomed Inc annual Return On Equity for 2020 was 22 %, a 10.6% decline from 2019.
Abiomed Inc annual Return On Equity for 2019 was 24.6 %, a 40.8% decline from 2018.

Return On Equity, Quarterly (%)

Return On Equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
Q3 2022	17.8	+6.46	+57.2%	Jul 1, 2022	Sep 30, 2022
Q2 2022	14.9	+2.7	+22.2%	Apr 1, 2022	Jun 30, 2022
Q1 2022	9.7	-8.8	-47.6%	Jan 1, 2022	Mar 31, 2022
Q4 2021	9.76	-7.63	-43.9%	Oct 1, 2021	Dec 31, 2021
Q3 2021	11.3	-7.61	-40.3%	Jul 1, 2021	Sep 30, 2021
Q2 2021	12.2	-2.94	-19.5%	Apr 1, 2021	Jun 30, 2021
Q1 2021	18.5	-1.27	-6.42%	Jan 1, 2021	Mar 31, 2021
Q4 2020	17.4	-7.26	-29.4%	Oct 1, 2020	Dec 31, 2020
Q3 2020	18.9	-4.44	-19%	Jul 1, 2020	Sep 30, 2020
Q2 2020	15.1	-13.7	-47.6%	Apr 1, 2020	Jun 30, 2020
Q1 2020	19.8	-11.6	-36.9%	Jan 1, 2020	Mar 31, 2020
Q4 2019	24.7	-4.38	-15.1%	Oct 1, 2019	Dec 31, 2019
Q3 2019	23.4	-3.49	-13%	Jul 1, 2019	Sep 30, 2019
Q2 2019	28.8	+3.9	+15.7%	Apr 1, 2019	Jun 30, 2019
Q1 2019	31.4	+13.4	+74.3%	Jan 1, 2019	Mar 31, 2019
Q4 2018	29	+13	+81.5%	Oct 1, 2018	Dec 31, 2018
Q3 2018	26.8	+8.78	+48.6%	Jul 1, 2018	Sep 30, 2018
Q2 2018	24.9	+8.19	+49.1%	Apr 1, 2018	Jun 30, 2018
Q1 2018	18	+5.32	+42%	Jan 1, 2018	Mar 31, 2018
Q4 2017	16	+3.65	+29.6%	Oct 1, 2017	Dec 31, 2017
Q3 2017	18.1	+6.43	+55.3%	Jul 1, 2017	Sep 30, 2017
Q2 2017	16.7	+4.83	+40.7%	Apr 1, 2017	Jun 30, 2017
Q1 2017	12.7	+1.4	+12.4%	Jan 1, 2017	Mar 31, 2017
Q4 2016	12.4	-27.2	-68.7%	Oct 1, 2016	Dec 31, 2016
Q3 2016	11.6	-33.9	-74.4%	Jul 1, 2016	Sep 30, 2016
Q2 2016	11.9	-39.3	-76.8%	Apr 1, 2016	Jun 30, 2016
Q1 2016	11.3	-43.3	-79.4%	Jan 1, 2016	Mar 31, 2016
Q4 2015	39.5	+29.1	+280%	Oct 1, 2015	Dec 31, 2015
Q3 2015	45.5	+39.5	+657%	Jul 1, 2015	Sep 30, 2015
Q2 2015	51.2	+46.7	+1029%	Apr 1, 2015	Jun 30, 2015
Q1 2015	54.6	+49.8	+1052%	Jan 1, 2015	Mar 31, 2015
Q4 2014	10.4	+5.32	+105%	Oct 1, 2014	Dec 31, 2014
Q3 2014	6.01	+1.94	+47.6%	Jul 1, 2014	Sep 30, 2014
Q2 2014	4.53	-2.8	-38.2%	Apr 1, 2014	Jun 30, 2014
Q1 2014	4.74	-6.3	-57.1%	Jan 1, 2014	Mar 31, 2014
Q4 2013	5.07	-5.31	-51.2%	Oct 1, 2013	Dec 31, 2013
Q3 2013	4.08	-6.85	-62.7%	Jul 1, 2013	Sep 30, 2013
Q2 2013	7.33	-0.25	-3.3%	Apr 1, 2013	Jun 30, 2013
Q1 2013	11	+9.75	+761%	Jan 1, 2013	Mar 31, 2013
Q4 2012	10.4	+12.9		Oct 1, 2012	Dec 31, 2012
Q3 2012	10.9			Jul 1, 2012	Sep 30, 2012
Q2 2012	7.58			Apr 1, 2012	Jun 30, 2012
Q1 2012	1.28			Jan 1, 2012	Mar 31, 2012
Q4 2011	-2.56			Oct 1, 2011	Dec 31, 2011

* An asterisk sign (*) next to the value indicates that the value is likely invalid.